Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA User Fee Staffing: The Objective Capacity Planning Adjuster Often Needs Subjective Review
Oct 17 2022
•
By
Derrick Gingery
The capacity planning adjustment has the CBER number of employees about right for drug review activities. • Source: Shutterstock
More from US FDA
More from Agency Leadership